Form 8-K - Current report:
SEC Accession No. 0000059478-25-000138
Filing Date
2025-05-08
Accepted
2025-05-08 16:34:55
Documents
14
Period of Report
2025-05-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K lly-20250505.htm   iXBRL 8-K 63449
  Complete submission text file 0000059478-25-000138.txt   285507

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20250505.xsd EX-101.SCH 4497
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20250505_def.xml EX-101.DEF 19611
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20250505_lab.xml EX-101.LAB 37978
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20250505_pre.xml EX-101.PRE 20830
16 EXTRACTED XBRL INSTANCE DOCUMENT lly-20250505_htm.xml XML 10543
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 25926875
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)